LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 131 of 166
Next
>>
>
3251 to 3275 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Mean Relative Cell Count	Standard Error of the Mean for Relative Cell Count	Mean Normalized Growth Rate Inhibition Value	Standard Error of the Mean for Normalized Growth Rate Inhibition Value
Hs 578T	SNS-032	3.33	uM	LJP6	0.1760	0.0357	-0.1373	0.0551
Hs 578T	SNS-032	10	uM	LJP6	0.1719	0.0385	-0.1485	0.0633
Hs 578T	Afatinib	0.04	uM	LJP6	0.9485	0.0029	0.9498	0.0032
Hs 578T	Afatinib	0.12	uM	LJP6	0.9455	0.0153	0.9438	0.0184
Hs 578T	Afatinib	0.37	uM	LJP6	0.9439	0.0089	0.9435	0.0123
Hs 578T	Afatinib	1.11	uM	LJP6	0.8966	0.0163	0.8987	0.0145
Hs 578T	Afatinib	3.33	uM	LJP6	0.8562	0.0248	0.8517	0.0342
Hs 578T	Afatinib	10	uM	LJP6	0.1696	0.0315	-0.1517	0.0231
Hs 578T	GSK1904529A	0.04	uM	LJP6	0.9553	0.0196	0.9597	0.0145
Hs 578T	GSK1904529A	0.12	uM	LJP6	0.9562	0.0088	0.9581	0.0075
Hs 578T	GSK1904529A	0.37	uM	LJP6	0.9622	0.0131	0.9645	0.0095
Hs 578T	GSK1904529A	1.11	uM	LJP6	0.9313	0.0093	0.9308	0.0137
Hs 578T	GSK1904529A	3.33	uM	LJP6	0.9512	0.0169	0.9506	0.0182
Hs 578T	GSK1904529A	10	uM	LJP6	0.9556	0.0114	0.9549	0.0133
Hs 578T	Linsitinib	0.04	uM	LJP5	0.9711	0.0249	0.9755	0.0199
Hs 578T	Linsitinib	0.12	uM	LJP5	0.9766	0.0152	0.9785	0.0136
Hs 578T	Linsitinib	0.37	uM	LJP5	0.9272	0.0138	0.9304	0.0112
Hs 578T	Linsitinib	1.11	uM	LJP5	0.9672	0.0324	0.9715	0.0274
Hs 578T	Linsitinib	3.33	uM	LJP5	0.9593	0.0171	0.9630	0.0123
Hs 578T	Linsitinib	10	uM	LJP5	0.8363	0.0288	0.8311	0.0414
Hs 578T	Ruxolitinib	0.04	uM	LJP5	0.9882	0.0040	0.9891	0.0031
Hs 578T	Ruxolitinib	0.12	uM	LJP5	0.9804	0.0275	0.9853	0.0224
Hs 578T	Ruxolitinib	0.37	uM	LJP5	0.9693	0.0173	0.9728	0.0130
Hs 578T	Ruxolitinib	1.11	uM	LJP5	0.9515	0.0032	0.9536	0.0020
Hs 578T	Ruxolitinib	3.33	uM	LJP5	0.8994	0.0086	0.9012	0.0123

|<
<<
Previous
Page 131 of 166
Next
>>
>
3251 to 3275 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)